Pembrolizumab: first experience with recurrent primary central nervous system (CNS) tumors
Crossref DOI link: https://doi.org/10.1007/s11060-016-2190-1
Published Online: 2016-07-04
Published Print: 2016-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Blumenthal, Deborah T.
Yalon, Michal
Vainer, Gilad W.
Lossos, Alexander
Yust, Shlomit
Tzach, Lior
Cagnano, Emanuela
Limon, Dror
Bokstein, Felix
License valid from 2016-07-04